Privium Fund Management (Uk) LTD Acelrx Pharmaceuticals Inc Transaction History

Privium Fund Management (Uk) LTD

  • $54.9 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Mar 25, 2022
BUY
$0.49 - $1.02 $6,908 - $14,380
14,099 New
14,099 $8,000
Q4 2021

Feb 08, 2022
SELL
$0.49 - $1.02 $6,908 - $14,380
-14,099 Closed
0 $0
Q1 2021

May 11, 2021
SELL
$1.25 - $2.77 $18,750 - $41,550
-15,000 Reduced 51.55%
14,099 $24,000
Q4 2020

Feb 12, 2021
BUY
$1.18 - $1.98 $34,336 - $57,616
29,099 New
29,099 $35,000

About ACELRX PHARMACEUTICALS INC

ACRX Quotes by TradingView
  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track Privium Fund Management (Uk) LTD Portfolio

Follow Privium Fund Management (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management (Uk) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email